Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:00 pm Sale | 13G | TCR2 THERAPEUTICS INC. TCRR | TANG CAPITAL PARTNERS LP | 0 0% | -4,215,864 (Position Closed) | View |
| 2023-05-05 4:37 pm Purchase | 13G | TCR2 THERAPEUTICS INC. TCRR | TANG CAPITAL PARTNERS LP | 4,215,864 10.7% | 1,476,917 (+53.92%) | View |
| 2023-02-14 4:00 pm Sale | 13G | TCR2 THERAPEUTICS INC. TCRR | TANG CAPITAL PARTNERS LP | 2,738,947 7.1% | -61,053 (-2.18%) | View |
| 2023-02-08 5:51 pm Sale | 13G | TCR2 THERAPEUTICS INC. TCRR | K2 PRINCIPAL FUND L.P. | 0 0% | -1,950,628 (Position Closed) | View |
| 2022-08-31 6:13 pm Purchase | 13G | TCR2 THERAPEUTICS INC. TCRR | K2 PRINCIPAL FUND L.P. | 1,950,628 5.05% | 1,950,628 (New Position) | View |
| 2022-07-08 4:57 pm Sale | 13G | TCR2 THERAPEUTICS INC. TCRR | BlackRock Inc. BLK | 1,037,694 2.7% | -1,364,051 (-56.79%) | View |
| 2022-03-04 4:00 pm Purchase | 13G | TCR2 THERAPEUTICS INC. TCRR | TANG CAPITAL PARTNERS LP | 2,800,000 7.3% | 2,800,000 (New Position) | View |
| 2022-02-14 5:07 pm Sale | 13G | TCR2 THERAPEUTICS INC. TCRR | Redmile Group LLC | 1,346,058 3.5% | -1,486,830 (-52.48%) | View |
| 2022-02-03 4:41 pm Sale | 13G | TCR2 THERAPEUTICS INC. TCRR | BlackRock Inc. BLK | 2,401,745 6.3% | -201,794 (-7.75%) | View |
| 2021-11-10 08:51 am Sale | 13G | TCR2 THERAPEUTICS INC. TCRR | WELLINGTON MANAGEMENT GROUP LLP | 1,131,347 2.96% | -2,622,017 (-69.86%) | View |
| 2021-02-16 4:09 pm Purchase | 13G | TCR2 THERAPEUTICS INC. TCRR | Redmile Group LLC | 2,832,888 8.5% | 1,033,700 (+57.45%) | View |
| 2021-02-16 1:29 pm Sale | 13G | TCR2 THERAPEUTICS INC. TCRR | ArrowMark Colorado Holdings LLC | 1,167,220 3.5% | -102,546 (-8.08%) | View |
| 2021-02-09 06:17 am Sale | 13G | TCR2 THERAPEUTICS INC. TCRR | Upnorth Investment Ltd | 1,281,392 3.8% | -856,027 (-40.05%) | View |
| 2021-02-02 2:56 pm Purchase | 13G | TCR2 THERAPEUTICS INC. TCRR | BlackRock Inc. BLK | 2,603,539 7.8% | 2,603,539 (New Position) | View |
| 2021-01-11 09:10 am Purchase | 13G | TCR2 THERAPEUTICS INC. TCRR | WELLINGTON MANAGEMENT GROUP LLP | 3,753,364 11.23% | 3,753,364 (New Position) | View |
| 2020-02-14 4:40 pm Purchase | 13G | TCR2 THERAPEUTICS INC. TCRR | ArrowMark Colorado Holdings LLC | 1,269,766 5.28% | 1,269,766 (New Position) | View |
| 2020-02-14 4:25 pm Sale | 13G | TCR2 THERAPEUTICS INC. TCRR | Redmile Group LLC | 1,799,188 7.5% | -8,068 (-0.45%) | View |
| 2020-02-10 06:09 am Unchanged | 13G | TCR2 THERAPEUTICS INC. TCRR | Upnorth Investment Ltd | 2,137,419 8.9% | 0 (Unchanged) | View |
| 2020-01-29 5:26 pm Purchase | 13G | TCR2 THERAPEUTICS INC. TCRR | F2 Capital I 2015 Ltd | 2,237,530 9.3% | 2,237,530 (New Position) | View |